A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease ...

Our skin protects us from everyday mechanical stresses, like friction, cuts, and impacts. A key part of this ...

The abstract will be available on the SITC website on or about November 4, 2025, at 9 a.m. ET.

Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

Q. I am in my 60s and live in Australia. For the past 20 years, I’ve had numerous basal and squamous cell skin cancers removed. Every six months, I’d have to get another check and get something ...

Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have jointly pioneered an innovative imaging technique combining Multispectral ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...

Australians led the way with research on the B vitamin nicotinamide to prevent basal and squamous cell skin cancers.